ABBV - CIK 0001551152
AbbVie Inc. (ABBV) reported net income of $4.23B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $4.23B | -1.2% |
| FY 2024 | $4.28B | -12.0% |
| FY 2023 | $4.86B | -58.9% |
| FY 2022 | $11.84B | +2.5% |
| FY 2021 | $11.54B | +150.0% |
| FY 2020 | $4.62B | -41.4% |
| FY 2019 | $7.88B | +38.6% |
| FY 2018 | $5.69B | +7.1% |
| FY 2017 | $5.31B |
AbbVie Inc. (ABBV) reported net income of $4.23B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2014 and fiscal 2025, AbbVie Inc.'s net income grew from $1.77B to $4.23B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -10.8% |
| FY 2016 | $5.95B | +15.7% |
| FY 2015 | $5.14B | +190.0% |
| FY 2014 | $1.77B | - |